Robert Peter Kadlec Mi Nk Therapeutics, Inc. (INKT) insider trading activity
Robert Peter Kadlec is of MiNK Therapeutics, Inc.. Currently has a direct ownership of 12,286 shares of INKT, which is worth approximately $6,388. The most recent transaction as insider was on Dec 01, 2024, when has been sold 12,286 shares (Common Stock) at a price of $0.73 per share, resulting in proceeds of $8,968. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
12.3K
n/a
3M change
n/a
12M change
Total Value Held
$6,388
RPK
Robert Peter Kadlec
New York, NY